CLINICAL-LABORATORY, IMMUNOLOGICAL, PATHOGENETIC MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME AND IDENTIFICATION OF EFFECTIVE TREATMENT REGIMENS (REVIEWS)

Musakov Mirzokhid Sabitdjanovich, Samatova Lobar Dilmurodovna, Turaxojaeva Sabokhat Sultanshikovna, Salaeva Muborak Saidabdullayevna, Tursunova Minavvar Ulug’bekovna

dc.contributor.author	Musakov Mirzokhid Sabitdjanovich, Samatova Lobar Dilmurodovna, Turaxojaeva Sabokhat Sultanshikovna, Salaeva Muborak Saidabdullayevna, Tursunova Minavvar Ulug’bekovna
dc.date.accessioned	2024-01-13T19:31:35Z
dc.date.available	2024-01-13T19:31:35Z
dc.date.issued	2023-05
dc.identifier.issn	2751-1731
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/9944
dc.description.abstract	Antiphospholipid syndrome (APS) is one of the leading causes of thrombosis. According to some estimates, the incidence of APS is about 5 new cases per 100,000 people per year and the prevalence is about 40-50 cases per 100,000 people [1], thus the problem of APS remains one of the most important in medicine.	en_US
dc.language.iso	en	en_US
dc.publisher	Spectrum Journal of Innovation, Reforms and Development	en_US
dc.subject	antiphospholipid syndrome (APS), antiphospholipid antibodies, lupus anticoagulant.	en_US
dc.title	CLINICAL-LABORATORY, IMMUNOLOGICAL, PATHOGENETIC MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME AND IDENTIFICATION OF EFFECTIVE TREATMENT REGIMENS (REVIEWS)	en_US
dc.type	Article	en_US